Loading resource…

World Health Organization
The guideline synthesises systematic review data on seasonal malaria chemoprevention (SMC), transmission‑directed antimalarial (TDA) interventions, and radical cure of Plasmodium vivax. It evaluates outcomes such as clinical malaria incidence, anaemia, severe disease, and safety considerations including G6PD testing. Recommendations are tailored to transmission settings, advising TDA primarily for very low‑to‑low transmission or post‑elimination contexts. The document also addresses implementation issues like feasibility, equity, and pharmacovigilance, and cites contributions from the GDG and various funding partners.
No account needed